891270-35-2 Usage
Uses
Used in Pharmaceutical Industry:
4-Pyrazol-1-yl-phenylboronic acid is used as a key reactant in the synthesis of diaminothienopyrimidine anti-malarial agents. These agents exhibit high oral activity, making them effective in treating malaria when administered through oral dosage forms. The incorporation of 4-Pyrazol-1-yl-phenylboronic acid in the synthesis process contributes to the development of potent and convenient anti-malarial medications.
Check Digit Verification of cas no
The CAS Registry Mumber 891270-35-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,1,2,7 and 0 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 891270-35:
(8*8)+(7*9)+(6*1)+(5*2)+(4*7)+(3*0)+(2*3)+(1*5)=182
182 % 10 = 2
So 891270-35-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H9BN2O2/c13-10(14)8-2-4-9(5-3-8)12-7-1-6-11-12/h1-7,13-14H
891270-35-2Relevant academic research and scientific papers
ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME
-
Paragraph 0433; 0435, (2020/06/15)
An organic light-emitting device includes an organometallic compound represented by M1(L1)n1(L2)n2, wherein L1 is a ligand represented by Formula 1-1: In Formula 1-1, *1 to *4 indicate a bi
ORGANIC COMPOUNDS
-
Page/Page column 9, (2008/06/13)
The present invention concerns a compound of formula (I), or a pharmaceutically acceptable salt, or solvate thereof, wherein the groups Ri- Rs are defined in the description, to compositions and use of the compounds in the treatment of diseases ameloriate
SPIROKETAL DERIVATIVE AND USE THEREOF AS DIABETIC MEDICINE
-
Page/Page column 33, (2008/06/13)
The present invention provides a compound of Formula (I): wherein R1, R2, R3 and R4 are each independently selected from a hydrogen atom, an optionally substituted C1-C6 alkyl group, an opt
